NM_015310.4:c.22-36062G>A
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_015310.4(PSD3):c.22-36062G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.72 in 152,028 control chromosomes in the GnomAD database, including 39,822 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.72 ( 39822 hom., cov: 32)
Consequence
PSD3
NM_015310.4 intron
NM_015310.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 1.19
Publications
2 publications found
Genes affected
PSD3 (HGNC:19093): (pleckstrin and Sec7 domain containing 3) Predicted to enable guanyl-nucleotide exchange factor activity and phospholipid binding activity. Predicted to be involved in regulation of ARF protein signal transduction and regulation of catalytic activity. Predicted to be located in membrane. Predicted to be active in ruffle membrane. [provided by Alliance of Genome Resources, Apr 2022]
PSD3 Gene-Disease associations (from GenCC):
- antecubital pterygium syndromeInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.763 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PSD3 | ENST00000327040.13 | c.22-36062G>A | intron_variant | Intron 1 of 15 | 1 | NM_015310.4 | ENSP00000324127.8 | |||
| PSD3 | ENST00000521475.1 | c.325-36062G>A | intron_variant | Intron 1 of 1 | 2 | ENSP00000428405.1 | ||||
| PSD3 | ENST00000521841.1 | n.402-36066G>A | intron_variant | Intron 1 of 1 | 4 |
Frequencies
GnomAD3 genomes AF: 0.720 AC: 109437AN: 151910Hom.: 39813 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
109437
AN:
151910
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.720 AC: 109490AN: 152028Hom.: 39822 Cov.: 32 AF XY: 0.719 AC XY: 53441AN XY: 74280 show subpopulations
GnomAD4 genome
AF:
AC:
109490
AN:
152028
Hom.:
Cov.:
32
AF XY:
AC XY:
53441
AN XY:
74280
show subpopulations
African (AFR)
AF:
AC:
26167
AN:
41454
American (AMR)
AF:
AC:
11137
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
AC:
2756
AN:
3470
East Asian (EAS)
AF:
AC:
3279
AN:
5164
South Asian (SAS)
AF:
AC:
3694
AN:
4810
European-Finnish (FIN)
AF:
AC:
7696
AN:
10552
Middle Eastern (MID)
AF:
AC:
233
AN:
294
European-Non Finnish (NFE)
AF:
AC:
52255
AN:
67968
Other (OTH)
AF:
AC:
1499
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1545
3090
4635
6180
7725
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
842
1684
2526
3368
4210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2406
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.